BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 26302976)

  • 1. Intraoperative blood loss is not a predictor of prognosis for pancreatic cancer.
    Arima K; Hashimoto D; Okabe H; Inoue R; Kaida T; Higashi T; Taki K; Nitta H; Hayashi H; Chikamoto A; Beppu T; Baba H
    Surg Today; 2016 Jul; 46(7):792-7. PubMed ID: 26302976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Impact of Intraoperative Blood Loss on the Survival of Patients With Stage II/III Pancreatic Cancer.
    Tamagawa H; Aoyama T; Yamamoto N; Kamiya M; Murakawa M; Atsumi Y; Numata M; Kazama K; Hara K; Yukawa N; Rino Y; Masuda M; Morinaga S
    In Vivo; 2020; 34(3):1469-1474. PubMed ID: 32354948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse oncologic effects of intraoperative transfusion during pancreatectomy for left-sided pancreatic cancer: the need for strict transfusion policy.
    Hwang HK; Jung MJ; Lee SH; Kang CM; Lee WJ
    J Hepatobiliary Pancreat Sci; 2016 Aug; 23(8):497-507. PubMed ID: 27295957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraoperative blood loss does not independently affect the survival outcome of gastric cancer patients who underwent curative resection.
    Zhao B; Huang X; Lu H; Zhang J; Luo R; Xu H; Huang B
    Clin Transl Oncol; 2019 Sep; 21(9):1197-1206. PubMed ID: 30689183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of postoperative major complications on prognosis after pancreatectomy for pancreatic cancer: a retrospective review.
    Watanabe Y; Nishihara K; Matsumoto S; Okayama T; Abe Y; Nakano T
    Surg Today; 2017 May; 47(5):555-567. PubMed ID: 27704248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term survival after resection of pancreatic cancer: a single-center retrospective analysis.
    Yamamoto T; Yagi S; Kinoshita H; Sakamoto Y; Okada K; Uryuhara K; Morimoto T; Kaihara S; Hosotani R
    World J Gastroenterol; 2015 Jan; 21(1):262-8. PubMed ID: 25574100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pancreatic carcinoma: reappraisal of surgical experiences in one Japanese university hospital.
    Yamaguchi K; Shimizu S; Yokohata K; Noshiro H; Chijiiwa K; Tanaka M
    Hepatogastroenterology; 1999; 46(30):3257-62. PubMed ID: 10626197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postoperative prognosis of pancreatic cancer with para-aortic lymph node metastasis: a multicenter study on 822 patients.
    Sho M; Murakami Y; Motoi F; Satoi S; Matsumoto I; Kawai M; Honda G; Uemura K; Yanagimoto H; Kurata M; Fukumoto T; Akahori T; Kinoshita S; Nagai M; Nishiwada S; Unno M; Yamaue H; Nakajima Y
    J Gastroenterol; 2015 Jun; 50(6):694-702. PubMed ID: 25341657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognostic significance of lymph node metastasis and intrapancreatic perineural invasion in pancreatic cancer after curative resection.
    Ozaki H; Hiraoka T; Mizumoto R; Matsuno S; Matsumoto Y; Nakayama T; Tsunoda T; Suzuki T; Monden M; Saitoh Y; Yamauchi H; Ogata Y
    Surg Today; 1999; 29(1):16-22. PubMed ID: 9934826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognosis of curatively resected pT4b gastric cancer with respect to invaded organ type.
    Min JS; Jin SH; Park S; Kim SB; Bang HY; Lee JI
    Ann Surg Oncol; 2012 Feb; 19(2):494-501. PubMed ID: 21837527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical impact of the lymph node ratio as a prognostic factor after resection of pancreatic cancer.
    Yamamoto Y; Ikoma H; Morimura R; Konishi H; Murayama Y; Komatsu S; Shiozaki A; Kuriu Y; Kubota T; Nakanishi M; Ichikawa D; Fujiwara H; Okamoto K; Sakakura C; Ochiai T; Otsuji E
    Anticancer Res; 2014 May; 34(5):2389-94. PubMed ID: 24778048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pancreatic neck cancer has specific and oncologic characteristics regarding portal vein invasion and lymph node metastasis.
    Hirono S; Kawai M; Okada K; Miyazawa M; Shimizu A; Kitahata Y; Ueno M; Yamaue H
    Surgery; 2016 Feb; 159(2):426-40. PubMed ID: 26253244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pancreatic neuroendocrine tumor: A multivariate analysis of factors influencing survival.
    Birnbaum DJ; Turrini O; Ewald J; Barbier L; Autret A; Hardwigsen J; Brunet C; Moutardier V; Le Treut YP; Delpero JR
    Eur J Surg Oncol; 2014 Nov; 40(11):1564-71. PubMed ID: 25086992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors after distal pancreatectomy with extended lymphadenectomy for invasive pancreatic adenocarcinoma of the body and tail.
    Shimada K; Sakamoto Y; Sano T; Kosuge T
    Surgery; 2006 Mar; 139(3):288-95. PubMed ID: 16546491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymph node ratio is an independent prognostic factor for patients after resection of pancreatic cancer.
    Zhan HX; Xu JW; Wang L; Zhang GY; Hu SY
    World J Surg Oncol; 2015 Mar; 13():105. PubMed ID: 25888902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of the depth of portal vein wall invasion after curative resection for pancreatic adenocarcinoma.
    Fukuda S; Oussoultzoglou E; Bachellier P; Rosso E; Nakano H; Audet M; Jaeck D
    Arch Surg; 2007 Feb; 142(2):172-9; discussion 180. PubMed ID: 17309969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of prognostic factors associated with early mortality after surgical resection for pancreatic cancer--under-analysis of cumulative survival curve.
    Takamori H; Hiraoka T; Kanemitsu K; Tsuji T; Hamada C; Baba H
    World J Surg; 2006 Feb; 30(2):213-8. PubMed ID: 16425074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pancreatic cancer with paraaortic lymph node metastasis: a contraindication for radical surgery?
    Yamada S; Nakao A; Fujii T; Sugimoto H; Kanazumi N; Nomoto S; Kodera Y; Takeda S
    Pancreas; 2009 Jan; 38(1):e13-7. PubMed ID: 18797422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and pathological features of five-year survivors after pancreatectomy for pancreatic adenocarcinoma.
    Kimura K; Amano R; Nakata B; Yamazoe S; Hirata K; Murata A; Miura K; Nishio K; Hirakawa T; Ohira M; Hirakawa K
    World J Surg Oncol; 2014 Nov; 12():360. PubMed ID: 25429841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reassessment of the clinical significance of portal-superior mesenteric vein invasion in borderline resectable pancreatic cancer.
    Hoshimoto S; Hishinuma S; Shirakawa H; Tomikawa M; Ozawa I; Wakamatsu S; Hoshi S; Hoshi N; Hirabayashi K; Ogata Y
    Eur J Surg Oncol; 2017 Jun; 43(6):1068-1075. PubMed ID: 28427822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.